This small marijuana biotech has garnered intense investor interest, with sharp swings up and down. What’s the real story behind CBIS? Read More

Cannabis player Cronos Group is flush with cash, after tobacco giant Altria bought a huge stake in the firm. Does Cronos deserve the hype? Read More

This clinical stage marijuana biotech is garnering eager investor interest. Is the company poised for greatness or disappointment? Read More